Live birth rate per woman · ovulation induction in polycystic ovarian syndrome
Recombinant follicle stimulating hormone showed no clear difference in live birth rate per woman compared with urinary‐derived gonadotrophins (low certainty).
1 finding from 1 review
OHSS · ovulation induction in polycystic ovarian syndrome
It is very uncertain whether human menopausal gonadotrophin or highly purified human menopausal… changes incidence of OHSS per woman compared with urinary follicle stimulating hormone (very low certainty).
1 finding from 1 review
Live birth rate per woman · anovulatory women with clomiphene citrate‐failure
Gonadotrophins probably leads to higher live birth rate per woman compared with continued clomiphene citrate (moderate certainty).
1 finding from 1 review
Multiple pregnancy rate · anovulatory women with clomiphene citrate‐failure
Gonadotrophins showed no clear difference in incidence of multiple pregnancy per woman compared with continued clomiphene citrate (moderate certainty).
1 finding from 1 review
Clinical pregnancy rate · anovulatory women with clomiphene citrate‐failure
Gonadotrophins probably leads to higher clinical pregnancy rate per woman compared with continued clomiphene citrate (moderate certainty).
1 finding from 1 review
Miscarriage · anovulatory women with clomiphene citrate‐failure
Gonadotrophins may leads to higher miscarriages per woman compared with continued clomiphene citrate (low certainty).
1 finding from 1 review
OHSS · anovulatory women with clomiphene citrate‐failure
1 finding from 1 review
Multiple pregnancy rate · ovulation induction in polycystic ovarian syndrome
Recombinant follicle stimulating hormone showed no clear difference in incidence of multiple pregnancy (per woman) compared with urinary‐derived gonadotrophins (low certainty).
1 finding from 1 review
Clinical pregnancy rate · ovulation induction in polycystic ovarian syndrome
Recombinant follicle stimulating hormone showed no clear difference in clinical pregnancy rate per woman compared with urinary‐derived gonadotrophins (low certainty).
1 finding from 1 review
Miscarriage · ovulation induction in polycystic ovarian syndrome
Recombinant follicle stimulating hormone showed no clear difference in miscarriage rate per woman compared with urinary‐derived gonadotrophins (low certainty).
1 finding from 1 review
OHSS · ovulation induction in polycystic ovarian syndrome
It is very uncertain whether recombinant follicle stimulating hormone changes incidence of OHSS per woman compared with urinary‐derived gonadotrophins (very low certainty).
1 finding from 1 review
Live birth rate per woman · ovulation induction in polycystic ovarian syndrome
It is very uncertain whether human menopausal gonadotrophin or highly purified human menopausal… changes live birth rate per woman compared with urinary follicle stimulating hormone (very low certainty).
1 finding from 1 review
Multiple pregnancy rate · ovulation induction in polycystic ovarian syndrome
It is very uncertain whether human menopausal gonadotrophin or highly purified human menopausal… changes incidence of multiple pregnancy (per woman) compared with urinary follicle stimulating hormone (very low certainty).
1 finding from 1 review
Clinical pregnancy rate · ovulation induction in polycystic ovarian syndrome
It is very uncertain whether human menopausal gonadotrophin or highly purified human menopausal… changes clinical pregnancy rate per woman compared with urinary follicle stimulating hormone (very low certainty).
1 finding from 1 review
Miscarriage · ovulation induction in polycystic ovarian syndrome
It is very uncertain whether human menopausal gonadotrophin or highly purified human menopausal… changes miscarriage rate per woman compared with urinary follicle stimulating hormone (very low certainty).
1 finding from 1 review
Live birth rate per woman · assisted reproduction
Hyaluronic acid‐selected sperm (HA‐ICSI) showed no clear difference in live birth per woman randomly assigned compared with ICSI (low certainty).
1 finding from 1 review
Miscarriage · assisted reproduction
It is very uncertain whether magnetic‐activated cell sorting (MACS) changes miscarriage per woman randomly assigned compared with ICSI (very low certainty).
1 finding from 1 review
Miscarriage per clinical pregnancy · assisted reproduction
It is very uncertain whether magnetic‐activated cell sorting (MACS) changes miscarriage per clinical pregnancy compared with ICSI (very low certainty).
1 finding from 1 review
Clinical pregnancy · assisted reproduction
It is very uncertain whether magnetic‐activated cell sorting (MACS) changes clinical pregnancy per woman randomly assigned compared with ICSI (very low certainty).
1 finding from 1 review
Live birth rate per woman · assisted reproduction
It is very uncertain whether zeta sperm selection changes live birth per woman randomly assigned compared with ICSI (very low certainty).
1 finding from 1 review